U.S. flag

An official website of the United States government

NM_000061.3(BTK):c.863G>A (p.Arg288Gln) AND X-linked agammaglobulinemia with growth hormone deficiency

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 8, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000690161.8

Allele description [Variation Report for NM_000061.3(BTK):c.863G>A (p.Arg288Gln)]

NM_000061.3(BTK):c.863G>A (p.Arg288Gln)

Gene:
BTK:Bruton tyrosine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq22.1
Genomic location:
Preferred name:
NM_000061.3(BTK):c.863G>A (p.Arg288Gln)
HGVS:
  • NC_000023.11:g.101359324C>T
  • NG_009616.1:g.31901G>A
  • NM_000061.3:c.863G>AMANE SELECT
  • NM_001287344.2:c.965G>A
  • NM_001287345.2:c.863G>A
  • NP_000052.1:p.Arg288Gln
  • NP_000052.1:p.Arg288Gln
  • NP_001274273.1:p.Arg322Gln
  • NP_001274274.1:p.Arg288Gln
  • LRG_128t1:c.863G>A
  • LRG_128:g.31901G>A
  • LRG_128p1:p.Arg288Gln
  • NC_000023.10:g.100614312C>T
  • NM_000061.2:c.863G>A
Protein change:
R288Q
Links:
dbSNP: rs1555978277
NCBI 1000 Genomes Browser:
rs1555978277
Molecular consequence:
  • NM_000061.3:c.863G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001287344.2:c.965G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001287345.2:c.863G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
X-linked agammaglobulinemia with growth hormone deficiency (IGHD3)
Synonyms:
IGHD III; Isolated growth hormone deficiency type 3; Growth hormone deficiency with hypogammaglobulinemia; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010615; MedGen: C0472813; Orphanet: 631; OMIM: 307200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000817839Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 8, 2024)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations in btk in patients with presumed X-linked agammaglobulinemia.

Conley ME, Mathias D, Treadaway J, Minegishi Y, Rohrer J.

Am J Hum Genet. 1998 May;62(5):1034-43.

PubMed [citation]
PMID:
9545398
PMCID:
PMC1377085

Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females.

Futatani T, Watanabe C, Baba Y, Tsukada S, Ochs HD.

Br J Haematol. 2001 Jul;114(1):141-9.

PubMed [citation]
PMID:
11472359
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000817839.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 288 of the BTK protein (p.Arg288Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with X-linked agammaglobulinemia (PMID: 9545398, 11472359, 12217331, 15661032). ClinVar contains an entry for this variant (Variation ID: 492813). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BTK protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects BTK function (PMID: 11206059). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024